These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5392913)

  • 21. Loss of resistance to methotrexate in L5178Y mouse leukemia grown in vitro.
    Courtenay VD; Robins AB
    J Natl Cancer Inst; 1972 Jul; 49(1):45-53. PubMed ID: 5037439
    [No Abstract]   [Full Text] [Related]  

  • 22. Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.
    Sedwick WD; Fyfe MJ; Brown OE; Frazer TA; Kutler M; Laszlo J
    Mol Pharmacol; 1979 Sep; 16(2):607-13. PubMed ID: 514260
    [No Abstract]   [Full Text] [Related]  

  • 23. The mechanism of action of methotrexate. I. Interaction with a low-affinity intracellular site required for maximum inhibition of deoxyribonucleic acid synthesis in L-cell mouse fibroblasts.
    Goldman ID
    Mol Pharmacol; 1974 Mar; 10(2):257-74. PubMed ID: 4859542
    [No Abstract]   [Full Text] [Related]  

  • 24. L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y.
    Capizzi RL; Summers WP; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():302-11. PubMed ID: 5289422
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of folate and folate analogs upon dihydrofolate reductase and DNA synthesis in kidneys of normal mice.
    Auletta AE; Gery AM; Parmar A; Davis J; Mishra L; Mead JA
    Life Sci; 1974 Apr; 14(8):1541-53. PubMed ID: 4829544
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of nitrous oxide on human bone marrow cells and its synergistic effect with methionine and methotrexate on functional folate deficiency.
    Kano Y; Sakamoto S; Sakuraya K; Kubota T; Hida K; Suda K; Takaku F
    Cancer Res; 1981 Nov; 41(11 Pt 1):4698-701. PubMed ID: 7306986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro.
    Van den Berg HW; Clarke R; Murphy RF
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1275-81. PubMed ID: 7200028
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of trimethoprim on folate-dependent DNA synthesis in human bone marrow.
    Sive J; Green R; Metz J
    J Clin Pathol; 1972 Mar; 25(3):194-7. PubMed ID: 5018713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cytotoxicity of methotrexate in mouse small intestine in relation to inhibition of folic acid reductase and of DNA synthesis.
    Margolis S; Philips FS; Sternberg SS
    Cancer Res; 1971 Dec; 31(12):2037-46. PubMed ID: 5120299
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y).
    Hoovis ML; Chu MY
    Cancer Res; 1973 Mar; 33(3):521-5. PubMed ID: 4734734
    [No Abstract]   [Full Text] [Related]  

  • 31. Abnormal deoxyuridine suppression as a rapid predictor for antimetabolite chemosensitivity: correlation with in vitro tests of growth inhibition.
    Block JB; Chlebowski RT; Dietrich MF; Isacoff WH
    Cancer Treat Rep; 1984 Apr; 68(4):631-6. PubMed ID: 6538809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorinated pyrimidines. XXXVII. Effects of 5-trifluoromethyl-2'-deoxyuridine on the synthesis of deoxyribonucleic acid of mammalian cells in culture.
    Fujiwara Y; Oki T; Heidelberger C
    Mol Pharmacol; 1970 May; 6(3):273-80. PubMed ID: 5462680
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphoblasts already in the DNA synthesis phase of the cell cycle can be reversibly arrested at the R/G transition.
    Lavoie J; Drouin R
    Chromosoma; 2001 Dec; 110(7):501-10. PubMed ID: 11862457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymidine kinase as a determinant of the response to 5-fluoro-2'-deoxyuridine in transplantable murine leukemias.
    Kessel D; Wodinsky I
    Mol Pharmacol; 1970 May; 6(3):251-4. PubMed ID: 5443530
    [No Abstract]   [Full Text] [Related]  

  • 35. An antifolate-induced lesion in newly synthesized DNA.
    Sedwick WD; Laszlo J
    Adv Enzyme Regul; 1980; 19():295-308. PubMed ID: 7337030
    [No Abstract]   [Full Text] [Related]  

  • 36. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radionucleoside incorporation by thymidine-synchronized cells.
    Drew RM; Commerford SL
    Radiat Res; 1967 Mar; 30(3):455-67. PubMed ID: 6022205
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical pharmacology of lipophilic diaminopyrimidine antifolates in mouse and human cells in vitro.
    Greco WR; Hakala MT
    Mol Pharmacol; 1980 Nov; 18(3):521-8. PubMed ID: 6970329
    [No Abstract]   [Full Text] [Related]  

  • 39. A clonal study of the reversible inhibition of muscle differentiation by the halogenated thymidine analog 5-bromodeoxyuridine.
    Coleman JR; Coleman AW; Hartline EJ
    Dev Biol; 1969 Jun; 19(6):527-48. PubMed ID: 5772670
    [No Abstract]   [Full Text] [Related]  

  • 40. Methotrexate inhibition of CCRF-CEM cultures of human lymphoblasts.
    Roberts D; Warmath EV
    Eur J Cancer (1965); 1975 Nov; 11(11):771-82. PubMed ID: 130240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.